he said: "our research shows that people, on average, believe that only 34 per cent of protection claims are paid out by insurance companies.
.
.
while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain.
.
.
.
.
.